Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia

计划入组 3 人 · 首次发布于 2020 年 5 月 18 日

A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.

计划入组 2 人 · 首次发布于 2023 年 3 月 2 日

A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia

计划入组 8 人 · 首次发布于 2021 年 6 月 14 日

Beta thalassaemia therapeutic (ASC Therapeutics)

Beta-Hydroxy-Beta-Methylbutyrate

ATP-IL12

Beta Bionics

Beta Innov

France

K-Group Beta, Inc.

United States

NHS Patient Achieves Transfusion Independence Following CRISPR Gene Therapy for Beta Thalassaemia

Chinese Base Editing Therapy Achieves First Clinical Cure of Beta Thalassaemia

NHS England Approves First CRISPR Gene-Editing Therapy for Beta Thalassaemia Treatment